164 related articles for article (PubMed ID: 26627)
21. Characteristics of the association between prothrombin fragment 2 and alpha-thrombin.
Myrmel KH; Lundblad RL; Mann KG
Biochemistry; 1976 Apr; 15(8):1767-73. PubMed ID: 944591
[TBL] [Abstract][Full Text] [Related]
22. The effects of salts and of ionic strength on the hydrolysis of TAME (p-toluenesulfonyl-L-arginine methyl ester) by thrombin and thrombokinase.
Roberts PS; Fleming PB
Thromb Diath Haemorrh; 1972 Jul; 27(3):573-83. PubMed ID: 4676964
[No Abstract] [Full Text] [Related]
23. Enhancement of respiratory syncytial virus-induced cytopathology by trypsin, thrombin, and plasmin.
Dubovi EJ; Geratz JD; Tidwell RR
Infect Immun; 1983 Apr; 40(1):351-8. PubMed ID: 6219957
[TBL] [Abstract][Full Text] [Related]
24. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
Wetsel RA; Kolb WP
J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
[TBL] [Abstract][Full Text] [Related]
25. "Inverse substrates" for trypsin-like enzymes.
Nozawa M; Tanizawa K; Kanaoka Y
J Pharmacobiodyn; 1980 Apr; 3(4):213-9. PubMed ID: 6451682
[TBL] [Abstract][Full Text] [Related]
26. Plasmin induces endothelium-dependent nitric oxide-mediated relaxation in the porcine coronary artery.
Fujiyoshi T; Hirano K; Hirano M; Nishimura J; Takahashi S; Kanaide H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):949-54. PubMed ID: 17272753
[TBL] [Abstract][Full Text] [Related]
27. The inactivation of hemostatic factors by hematin.
Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
[TBL] [Abstract][Full Text] [Related]
28. ENZYMATIC AND PHYSIOLOGICAL STUDIES ON THE PROTEASES HETEROGENOUS TO THE BODY. I. SUBSTRATE SPECIFICITY, INHIBITORS, AND THE PHYSIOLOGICAL FATE OF ASPERKINASE.
OSHIBA S; MIHARA H; HATA S; OKAMOTO S
Kobe J Med Sci; 1963 Dec; 18():139-49. PubMed ID: 14160534
[No Abstract] [Full Text] [Related]
29. Steady-state kinetics of trypsin-catalyzed hydrolysis of a synthetic substrate, dansyl-D-arginine methyl ester.
Goto S
J Biochem; 1980 Feb; 87(2):399-406. PubMed ID: 7358645
[TBL] [Abstract][Full Text] [Related]
30. Kinetics and mechanism of catalysis by proteolytic enzymes. The kinetics of hydrolysis of esters of gamma-guanidino-L-alpha-toluene-p-sulphonamidobutyric acid by bovine trypsin and thrombin.
Baird JB; Curragh EF; Elmore DT
Biochem J; 1965 Sep; 96(3):733-8. PubMed ID: 5862413
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin.
Lanchantin GF; Plesset ML; Friedmann JA; Hart DW
Proc Soc Exp Biol Med; 1966 Feb; 121(2):444-9. PubMed ID: 4160504
[No Abstract] [Full Text] [Related]
32. [Interaction of trypsin with a trypsin inhibitor from bovine colostrum].
Cechová D; Kazanskaia NF; Larionova NI; Berezin IV
Biokhimiia; 1975; 40(1):145-9. PubMed ID: 1138994
[TBL] [Abstract][Full Text] [Related]
33. The activity of plasma, serum, thrombin, and plasmin toward synthetic trypsin substrates.
Szczeklik E; Orlowski M; Szczeklik A; Narczewska B
Thromb Diath Haemorrh; 1968 Mar; 19(1):99-106. PubMed ID: 4231461
[No Abstract] [Full Text] [Related]
34. pH effects in plasmin-catalysed hydrolysis of alpha-N-benzoyl-L-arginine compounds.
Christensen U
Biochim Biophys Acta; 1975 Aug; 397(2):459-67. PubMed ID: 239753
[TBL] [Abstract][Full Text] [Related]
35. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
Harpel PC; Mosesson MW
J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the catalytic properties of thrombin and trypsin by kinetic analysis on the basis of active enzyme concentration.
Takasaki SI; Kasai KI; Ishii SI
J Biochem; 1975 Dec; 78(6):1275-85. PubMed ID: 1241585
[TBL] [Abstract][Full Text] [Related]
37. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
38. Use of a new synthetic substrate, Nalpha-tosyl-L-arginine-P-nitroanilide (TAPA), for determining trypsin activity in the duodenal contents.
Malis F; Kasafírek E; Fric P; Josífko M
Acta Univ Carol Med Monogr; 1977; (79 Pt 3):131-8. PubMed ID: 615474
[TBL] [Abstract][Full Text] [Related]
39. Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine.
Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Okamoto S; Funahara Y; Hijikata A
J Med Chem; 1980 Aug; 23(8):830-6. PubMed ID: 7401110
[TBL] [Abstract][Full Text] [Related]
40. [Antithrombic activity of N(alpha)-lauroyl-L-arginine ethyl ester (LAE) and 9-fluorenylmethoxycarbonyl-L-arginine methyl ester (Fmoc-L-Arg-OMe)].
Poiarkov AA; Poiarkova SA; Kukhar' VP
Ukr Biokhim Zh (1999); 2007; 79(1):124-31. PubMed ID: 18030741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
